Published in J Clin Invest on September 01, 1992
Clostridium difficile-associated diarrhea in adults. CMAJ (2004) 4.27
CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc Natl Acad Sci U S A (1994) 2.22
Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci U S A (2004) 1.64
Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens. J Clin Microbiol (1994) 1.56
Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect Immun (1996) 1.37
The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives. Gut Microbes (2010) 1.37
Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. J Clin Invest (1996) 1.26
Models for the study of Clostridium difficile infection. Gut Microbes (2012) 1.16
Clostridium difficile and the microbiota. J Clin Invest (2014) 1.09
Clostridium difficile infection in the twenty-first century. Emerg Microbes Infect (2013) 1.09
The enterotoxicity of Clostridium difficile toxins. Toxins (Basel) (2010) 1.07
Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections. J Pediatr (2013) 0.98
Clostridium difficile infection in children hospitalized due to diarrhea. Eur J Clin Microbiol Infect Dis (2013) 0.92
Human Clostridium difficile infection: altered mucus production and composition. Am J Physiol Gastrointest Liver Physiol (2014) 0.87
Clostridium difficile Infection in Children: Current State and Unanswered Questions. J Pediatric Infect Dis Soc (2012) 0.86
The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease. Dig Dis Sci (2014) 0.86
Diagnosis of Clostridium difficile Infections in Children. J Clin Microbiol (2016) 0.83
Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection. Anaerobe (2016) 0.79
Escherichia coli strain RDEC-1 AF/R1 endogenous fimbrial glycoconjugate receptor molecules in rabbit small intestine. Infect Immun (2001) 0.77
Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk. Microbiome (2016) 0.75
The role of Clostridium difficile in the paediatric and neonatal gut - a narrative review. Eur J Clin Microbiol Infect Dis (2016) 0.75
Clostridium difficile in Children: To Treat or Not to Treat? Pediatr Gastroenterol Hepatol Nutr (2014) 0.75
Understanding new concepts: Clostridium difficile infection in pouch patients. Dig Dis Sci (2014) 0.75
Clostridium difficile: an emerging pathogen in children. Discov Med (2012) 0.75
Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective. Curr Gastroenterol Rep (2017) 0.75
Clostridium difficile infections in young infants: Case presentations and literature review. IDCases (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med (1978) 14.65
METHOD FOR ASSAY OF INTESTINAL DISACCHARIDASES. Anal Biochem (1964) 9.88
Nosocomial acquisition of Clostridium difficile infection. N Engl J Med (1989) 7.72
Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis (1977) 7.68
Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun (1982) 6.88
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Glucose transport in isolated brush border membrane from rat small intestine. J Biol Chem (1973) 4.75
Role of toxigenic and invasive bacteria in acute diarrhea of childhood. N Engl J Med (1975) 4.23
Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun (1990) 4.06
Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem (1989) 3.99
Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem (1988) 3.34
Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest (1988) 3.12
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun (1986) 2.89
Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology (1987) 2.54
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. J Clin Microbiol (1982) 2.52
Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut (1986) 1.93
Clostridium difficile toxin in asymptomatic neonates. J Pediatr (1982) 1.88
Investigations of avidin and biotin for imaging applications. J Nucl Med (1987) 1.88
Incidence and origin of Clostridium difficile in neonates. J Clin Microbiol (1984) 1.68
Chemistry of lipid of the posthemyolytic residue or stroma of erythrocytes. XVI. Occurrence of ceramide pentasaccharide in the membrane of erythrocytes and reticulocytes of rabbit. J Biochem (1968) 1.68
Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal Gal alpha 1-3Gal beta 1-4GlcNAc sequences. Arch Biochem Biophys (1987) 1.51
Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J Clin Invest (1988) 1.41
Pathogenesis of shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine. J Infect Dis (1988) 1.38
C. difficile toxin A increases intestinal permeability and induces Cl- secretion. Am J Physiol (1990) 1.37
Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitis. Gut (1980) 1.37
Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein. J Clin Invest (1991) 1.34
Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. Infect Immun (1982) 1.33
Comparative study of Clostridium difficile toxin A and cholera toxin in rabbit ileum. Gastroenterology (1989) 1.30
Differential cytotoxic effects of toxins A and B isolated from Clostridium difficile. Infect Immun (1984) 1.28
Cellular internalisation of Clostridium difficile toxin A. Microb Pathog (1987) 1.20
Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin. Infect Immun (1981) 1.19
Tissue specific expression and developmental regulation of two genes coding for rat fatty acid binding proteins. J Biol Chem (1985) 1.17
Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine. Gut (1990) 1.15
Age-related differences in receptors for Escherichia coli heat-stable enterotoxin in the small and large intestine of children. Gastroenterology (1988) 1.11
Clostridium difficile cytotoxin inhibits protein synthesis in fibroblasts and intestinal mucosa. Gastroenterology (1986) 1.11
Intestinal colonization of infant hamsters with Clostridium difficile. Infect Immun (1983) 1.05
Isolation and characterization of an I-active ceramide decasaccharide from rabbit erythrocyte membranes. Biochemistry (1981) 1.04
Developmental changes in intestinal glycosyl-transferase activities. Pediatr Res (1987) 1.02
Small and large intestinal guanylate cyclase activity in children: effect of age and stimulation by Escherichia coli heat-stable enterotoxin. Pediatr Res (1987) 0.98
Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters. Infect Immun (1991) 0.97
The immature rat small intestine exhibits an increased sensitivity and response to Escherichia coli heat-stable enterotoxin. Pediatr Res (1986) 0.92
Developmental changes in galactosyltransferase activity in the rat small intestine. Biochim Biophys Acta (1989) 0.91
Developmental changes in the activities of sialyl- and fucosyltransferases in rat small intestine. Biochim Biophys Acta (1986) 0.88
Structural and functional maturation of rat gastrointestinal barrier with thyroxine. Am J Physiol (1987) 0.84
Differentiation of glycoprotein synthesis in fetal rat colon. Am J Physiol (1978) 0.80
Neonatal shigellosis with bowel perforation. Pediatr Infect Dis (1985) 0.77
Clostridium difficile colitis. N Engl J Med (1994) 9.31
Clostridium difficile infection. Annu Rev Med (1998) 3.63
Uptake and transport of macromolecules by the intestine. Possible role in clinical disorders. Gastroenterology (1974) 3.33
Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest (1988) 3.12
Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest (1995) 2.91
Rational approach to iron-deficiency anaemia in premenopausal women. Lancet (1999) 2.83
Intestinal uptake of macromolecules: effect of oral immunization. Science (1972) 2.80
Experimental clindamycin-associated colitis in rabbits. Evidence of toxin-mediated mucosal damage. Gastroenterology (1978) 2.63
Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci U S A (2000) 2.61
A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J Virol (1999) 2.58
Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology (1987) 2.54
Small intestinal permeability to macromolecules. Transmission of horseradish peroxidase into mesenteric lymph and portal blood. Lab Invest (1971) 2.46
Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J (2001) 2.34
Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology (1994) 2.28
Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J Clin Invest (1994) 2.25
Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease. Lancet (1980) 2.24
CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc Natl Acad Sci U S A (1994) 2.22
Spontaneous rupture of the esophagus: a 30-year experience. Ann Thorac Surg (1989) 2.22
Small intestinal absorption of horseradish peroxidase. A cytochemical study. Lab Invest (1971) 2.20
Immune factors in breast milk and the development of atopic disease. J Pediatr Gastroenterol Nutr (2012) 2.02
Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones. J Clin Invest (1981) 1.99
Purification and properties of Clostridium difficile cytotoxin B. J Biol Chem (1986) 1.97
Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr (1991) 1.97
Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut (1997) 1.96
Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology (1995) 1.93
Mucin biophysics. Annu Rev Physiol (1995) 1.93
Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci U S A (1998) 1.90
HTLV-I tax gene product activates transcription via pre-existing cellular factors and cAMP responsive element. J Biol Chem (1989) 1.87
Intestinal antibodies. N Engl J Med (1977) 1.82
Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes. Pediatr Res (2001) 1.80
Mineral trioxide aggregate: a new material for endodontics. J Am Dent Assoc (1999) 1.79
Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats. Proc Natl Acad Sci U S A (1997) 1.70
p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J Clin Invest (2000) 1.68
Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol Cell (2001) 1.68
Macromolecular absorption. Mechanism of horseradish peroxidase uptake and transport in adult and neonatal rat intestine. J Cell Biol (1972) 1.66
Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg (1997) 1.66
Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology (1992) 1.62
Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis. J Clin Invest (1998) 1.57
Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology (1993) 1.56
Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ (2004) 1.54
Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg (1997) 1.53
Protein uptake by the intestine: evidence for absorption of intact macromolecules. Gastroenterology (1974) 1.53
Intestinal uptake of macromolecules. II. Effect of parenteral immunization. J Immunol (1973) 1.53
Naturally occurring variability in anesthetic potency among inbred mouse strains. Anesth Analg (2000) 1.51
Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun (1999) 1.50
Yersinia enterocolitica infection: report of two cases. Can J Public Health (1973) 1.49
Intestinal uptake of macromolecules. III. Studies on the mechanism by which immunization interferes with antigen uptake. J Immunol (1975) 1.49
Human fetal enterocytes in vitro: modulation of the phenotype by extracellular matrix. Proc Natl Acad Sci U S A (1996) 1.49
Ultrastructural effects of Clostridium difficile toxin B on smooth muscle cells and fibroblasts. Exp Cell Res (1983) 1.46
Mimicking natural superhydrophobic surfaces and grasping the wetting process: a review on recent progress in preparing superhydrophobic surfaces. Adv Colloid Interface Sci (2011) 1.46
Antigenicity of infant formulas: role of immature intestine on protein permeability. J Pediatr (1978) 1.45
Video-assisted thoracic surgery: primary therapy for spontaneous pneumothorax? Ann Thorac Surg (1995) 1.42
Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. Gastroenterology (1981) 1.42
Epidemiological evaluation of the outcomes of nonsurgical root canal treatment in a large cohort of insured dental patients. J Endod (2001) 1.42
Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology (1993) 1.42
Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J Clin Invest (1988) 1.41
Arthritis associated with intestinal-bypass procedure for morbid obesity. Complement activation and characterization of circulating cryoproteins. N Engl J Med (1976) 1.39
Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr (2001) 1.39
Treatment of gastrointestinal infections. Gastroenterology (2000) 1.39
Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect Immun (1996) 1.37
C. difficile toxin A increases intestinal permeability and induces Cl- secretion. Am J Physiol (1990) 1.37
Ketotifen inhibits Clostridium difficile toxin A-induced enteritis in rat ileum. Gastroenterology (1993) 1.36
Antigen absorption from the small intestine and gastrointestinal disease. Pediatr Clin North Am (1975) 1.36
Stimulation by immune complexes of mucus release from goblet cells of the rat small intestine. Science (1977) 1.35
Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein. J Clin Invest (1991) 1.34
Chronic nonspecific diarrhea: dietary relationships. Pediatrics (1979) 1.34
Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science (1981) 1.34
Growth failure and inflammatory bowel disease: approach to treatment of a complicated adolescent problem. Pediatrics (1983) 1.33
Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding. Gastroenterology (1992) 1.32
Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile. Gastroenterology (1984) 1.32
Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro. Am J Physiol (1992) 1.32
Toxic megacolon. Lancet (1998) 1.31
Comparative study of Clostridium difficile toxin A and cholera toxin in rabbit ileum. Gastroenterology (1989) 1.30
Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes. J Biol Chem (2001) 1.29
Intestinal goblet cell mucus release. II. In vivo stimulation by antigen in the immunized rat. J Immunol (1979) 1.29
Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics) Anesth Analg (1998) 1.28
Smear layer removal effects on apical leakage. J Endod (1986) 1.28
Blockade of AMPA receptors and volatile anesthetics: reduced anesthetic requirements in GluR2 null mutant mice for loss of the righting reflex and antinociception but not minimum alveolar concentration. Anesthesiology (2001) 1.27
Experimental colon cancer. Gastroenterology (1978) 1.27
Profound increase in viscosity and aggregation of pig gastric mucin at low pH. Am J Physiol (1991) 1.27
Development of immune function in the intestine and its role in neonatal diseases. Pediatr Clin North Am (1996) 1.26
Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B. Infect Immun (1995) 1.26